mouse anti il 1β (Proteintech)
96
Structured Review
Proteintech
mouse anti il 1β
Mouse Anti Il 1β, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 2423 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+il+1%CE%B2/IL-1+beta+Antibody/pmc13658527-95-13-16
Average 96 stars, based on 2423 article reviews
Mouse Anti Il 1β, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 2423 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+il+1%CE%B2/IL-1+beta+Antibody/pmc13658527-95-13-16
Average 96 stars, based on 2423 article reviews
mouse anti il 1β - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
Incubation:Article Title: Retrosplenial cortex vulnerability links severe hypoglycemia to cognitive impairment through neuron–microglia crosstalk Article Snippet: Equal amounts of protein were separated on 8% or 10% sodium dodecyl sulfate‒polyacrylamide gels and transferred to polyvinylidene difluoride membranes (Millipore, IPVH00010). .. The membranes were blocked with 5% skim milk for one hour at room temperature, followed by overnight incubation at 4°C with primary antibodies [ Article Title: Histone H3K9 lactylation activates the TXNIP/NLRP3 pathway to drive macrophage inflammation after spinal cord injury. Article Snippet: Membranes were blocked in 5% nonfat milk/TBST for 1.5 h, washed, and incubated overnight at 4 ◦C with primary antibodies in TBST: anti- Pankla (PTM-1401, PTM Bio, 1:1000), anti- Histone H3 (HL102-01, Transgen, 1:1000), anti-β-actin (66009-1-Ig, Proteintech, 1:5000), anti-H3K9la (PTM-1421RM, PTM Bio, 1:1000), anti-H3K14la (PTM-1414, PTM Bio, 1:1000), anti-H3K18la (PTM-1406RM, PTM Bio, 1:1000), anti-H3K9ac (PTM-112RM, PTM Bio, 1:5000), anti- H3K9me (PTM-643, PTM Bio, 1:1000), anti-H3K27ac (PTM-116 RM, PTM Bio, 1:1000), anti- Caspase 1(81482-1-RR, Proteintech, 1:10000), antiNLRP3(MA5-32255, Invitrogen, 1:1000), anti-TXNIP (14715, CST, 1:1000), anti-IL-1β(26048-1-AP, Proteintech, 1:3000), anti-TNF- α(17590-1-AP, Proteintech, 1:5000), anti-iNOS(22226-1-AP, Proteintech, 1:500). .. Membranes were blocked in 5% nonfat milk/TBST for 1.5 h, washed, and incubated overnight at 4 ◦C with primary antibodies in TBST: anti- Pankla (PTM-1401, PTM Bio, 1:1000), anti- Histone H3 (HL102-01, Transgen, 1:1000), anti-β-actin (66009-1-Ig, Proteintech, 1:5000), anti-H3K9la (PTM-1421RM, PTM Bio, 1:1000), anti-H3K14la (PTM-1414, PTM Bio, 1:1000), anti-H3K18la (PTM-1406RM, PTM Bio, 1:1000), anti-H3K9ac (PTM-112RM, PTM Bio, 1:5000), anti- H3K9me (PTM-643, PTM Bio, 1:1000), anti-H3K27ac (PTM-116 RM, PTM Bio, 1:1000), anti- Caspase 1(81482-1-RR, Proteintech, 1:10000), antiNLRP3(MA5-32255, Invitrogen, 1:1000), anti-TXNIP (14715, CST, 1:1000), anti-IL-1β( Article Title: A dual-functional Janus nanofibrous membrane as an immunomodulatory barrier for periodontitis regeneration under diabetic conditions Article Snippet: .. For immunohistochemical (IHC) analysis, sections were incubated with the following primary antibodies: OCN (Proteintech, 16157-1-AP), RUNX2 (Proteintech, 207001-1-AP), IL-6 (Proteintech,26404-1-AP), anti-TNF-α (Proteintech, 17590-1-AP), and Article Title: Histone H3K9 lactylation activates the TXNIP/NLRP3 pathway to drive macrophage inflammation after spinal cord injury Article Snippet: Membranes were blocked in 5% nonfat milk/TBST for 1.5 h, washed, and incubated overnight at 4 °C with primary antibodies in TBST: anti- Pankla (PTM-1401, PTM Bio, 1:1000), anti- Histone H3(HL102-01, Transgen, 1:1000), anti-β-actin (66009-1-Ig, Proteintech, 1:5000), anti-H3K9la (PTM-1421RM, PTM Bio, 1:1000), anti-H3K14la (PTM-1414, PTM Bio, 1:1000), anti-H3K18la (PTM-1406RM, PTM Bio, 1:1000), anti-H3K9ac (PTM-112RM, PTM Bio, 1:5000), anti- H3K9me (PTM-643, PTM Bio, 1:1000), anti-H3K27ac (PTM-116 RM, PTM Bio, 1:1000), anti- Caspase 1(81482-1-RR, Proteintech, 1:10000), anti- NLRP3(MA5-32255, Invitrogen, 1:1000), anti-TXNIP (14715, CST, 1:1000), anti-IL-1β(26048-1-AP, Proteintech, 1:3000), anti-TNF-α(17590-1-AP, Proteintech, 1:5000), anti-iNOS(22226-1-AP, Proteintech, 1:500). .. Membranes were blocked in 5% nonfat milk/TBST for 1.5 h, washed, and incubated overnight at 4 °C with primary antibodies in TBST: anti- Pankla (PTM-1401, PTM Bio, 1:1000), anti- Histone H3(HL102-01, Transgen, 1:1000), anti-β-actin (66009-1-Ig, Proteintech, 1:5000), anti-H3K9la (PTM-1421RM, PTM Bio, 1:1000), anti-H3K14la (PTM-1414, PTM Bio, 1:1000), anti-H3K18la (PTM-1406RM, PTM Bio, 1:1000), anti-H3K9ac (PTM-112RM, PTM Bio, 1:5000), anti- H3K9me (PTM-643, PTM Bio, 1:1000), anti-H3K27ac (PTM-116 RM, PTM Bio, 1:1000), anti- Caspase 1(81482-1-RR, Proteintech, 1:10000), anti- NLRP3(MA5-32255, Invitrogen, 1:1000), anti-TXNIP (14715, CST, 1:1000), anti-IL-1β( Immunohistochemical staining:Article Title: A dual-functional Janus nanofibrous membrane as an immunomodulatory barrier for periodontitis regeneration under diabetic conditions Article Snippet: .. For immunohistochemical (IHC) analysis, sections were incubated with the following primary antibodies: OCN (Proteintech, 16157-1-AP), RUNX2 (Proteintech, 207001-1-AP), IL-6 (Proteintech,26404-1-AP), anti-TNF-α (Proteintech, 17590-1-AP), and Immunohistochemistry:Article Title: A dual-functional Janus nanofibrous membrane as an immunomodulatory barrier for periodontitis regeneration under diabetic conditions Article Snippet: .. For immunohistochemical (IHC) analysis, sections were incubated with the following primary antibodies: OCN (Proteintech, 16157-1-AP), RUNX2 (Proteintech, 207001-1-AP), IL-6 (Proteintech,26404-1-AP), anti-TNF-α (Proteintech, 17590-1-AP), and Analysis:Article Title: A dual-functional Janus nanofibrous membrane as an immunomodulatory barrier for periodontitis regeneration under diabetic conditions Article Snippet: .. For immunohistochemical (IHC) analysis, sections were incubated with the following primary antibodies: OCN (Proteintech, 16157-1-AP), RUNX2 (Proteintech, 207001-1-AP), IL-6 (Proteintech,26404-1-AP), anti-TNF-α (Proteintech, 17590-1-AP), and other:Article Title: From multi-omics discovery to experimental validation: GPC4 mediates the anti-neuroinflammatory effects of Buyang Huanwu decoction via TLR4/NF-κB signaling in ischemic stroke with Qi deficiency and blood stasis syndrome. Article Snippet: Ethnopharmacological relevance: Buyang Huanwu Decoction (BYHW) is a classical Chinese herbal formula derived from Wang Qingren's “Medical Forest Corrections” during the Qing Dynasty.. Research has consistently demonstrated that BYHW possesses substantial traditional usage evidence as an ethnic medicine for treating ischemic stroke (IS) with Qi deficiency and blood stasis (QDBS) Syndrome.. Aim of the study: Identifying key differentially expressed proteins in BYHW treatment for IS with QDBS Syndrome and its anti-neuroinflammatory mechanism of action. |